M.A. Reveley
Impact in
- Psychiatry and Mental health top 1%
- Schizophrenia research and treatment
- Electroconvulsive Therapy Studies
- Bipolar Disorder and Treatment
- Biological Psychiatry top 5%
Papers in
-
- Tryptophan and brain disorders 4
-
- Schizophrenia research and treatment 14
- Bipolar Disorder and Treatment 5
- Co-authors
- M. SandlerVivette GloverS.M. DursunA. Olufemi WilliamsT. KolakowskaB. M. MandelbroteMark ArdernTrevor J. Crawford
- Journals
- The British Journal of Psychiatry (4 papers)Schizophrenia Research (3 papers)Psychological Medicine (3 papers)Journal of Psychopharmacology (3 papers)The Lancet (3 papers)
- Partner nations
- United KingdomCanadaNigeria
In The Last Decade
M.A. Reveley
36 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 99
- Psychiatry and Mental health 878
- Biological Psychiatry 101
- Cognitive Neuroscience 431
- Cellular and Molecular Neuroscience 255
- Philosophy 138
Countries citing papers authored by M.A. Reveley
This map shows the geographic impact of M.A. Reveley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.A. Reveley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.A. Reveley more than expected).
Fields of papers citing papers by M.A. Reveley
This network shows the impact of papers produced by M.A. Reveley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.A. Reveley. The network helps show where M.A. Reveley may publish in the future.
Co-authors
The 25 scholars most cited alongside M.A. Reveley, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 24 | |
| 2 | 2006 | 18 | |
| 3 | Eye-Head Coordination in Schizophrenia | 2003 | 1 |
| 4 | 2003 | 62 | |
| 5 | Effects of clozapine and typical antipsychotic drugs on plasma 5-HT turnover and impulsivity in patients with schizophrenia: a cross-sectional study. | 2000 | 30 |
| 6 | 2000 | 145 | |
| 7 | The effects of clozapine on levels of total cholesterol and related lipids in serum of patients with schizophrenia: a prospective study. | 1999 | 43 |
| 8 | 1998 | 6 | |
| 9 | 1996 | 20 | |
| 10 | 1995 | 131 | |
| 11 | 1995 | 84 | |
| 12 | 1995 | 11 | |
| 13 | 1993 | 6 | |
| 14 | 1987 | 92 | |
| 15 | 1984 | 20 | |
| 16 | 1983 | 6 | |
| 17 | 1981 | 38 | |
| 18 | 1980 | 1 | |
| 19 | 1980 | 11 | |
| 20 | 1980 | 103 |
About M.A. Reveley
M.A. Reveley is a scholar working on Biological Psychiatry, Psychiatry and Mental health, Cognitive Neuroscience, Neurology and Experimental and Cognitive Psychology, having authored 37 papers that have together received 1.5k indexed citations. Recurring topics across this work include Schizophrenia research and treatment (14 papers), Bipolar Disorder and Treatment (5 papers), Tryptophan and brain disorders (4 papers), Treatment of Major Depression (4 papers), Advanced Neuroimaging Techniques and Applications (4 papers), Neural and Behavioral Psychology Studies (4 papers), Neurological disorders and treatments (3 papers) and Cardiovascular Syncope and Autonomic Disorders (3 papers). The work is most often cited by research in Psychiatry and Mental health (878 citations), Biological Psychiatry (101 citations), Cognitive Neuroscience (431 citations), Cellular and Molecular Neuroscience (255 citations) and Philosophy (138 citations). M.A. Reveley has collaborated with scholars based in United Kingdom, Canada and Nigeria. Frequent co-authors include M. Sandler, Vivette Glover, S.M. Dursun, A. Olufemi Williams, T. Kolakowska, B. M. Mandelbrote, Mark Ardern, Trevor J. Crawford, Christopher Kennard and A.M. Reveley. Their work appears in journals such as The British Journal of Psychiatry, Schizophrenia Research, Psychological Medicine, Journal of Psychopharmacology and The Lancet.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.